Published June 23, 2015 | Version v1
Patent Open

Antibody-light fusion products for cancer therapeutics

  • 1. University of Chicago

Contributors

Description

Antibody-LIGHT fusion products or conjugates stimulate immunity against tumors and eradicate metastases. Tumor-specific antibodies coupled with LIGHT effectively target metastatic tumors and reduces cancer metastases.

Files

US9061073.pdf

Files (1.1 MB)

Name Size Download all
md5:a1c8e0f5e9cc0b6d4bdd4d33988ec97d
1.1 MB Preview Download

Additional details

Identifiers

Patent number
US 201213563372 A
Patent application number
US 9061073 B2
Other
oai:uchicago.tind.io:8301

Dates

Patent filed
2012-07-31

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Pathology